Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome.
Shioda N, Yabuki Y, Yamaguchi K, Onozato M, Li Y, Kurosawa K, Tanabe H, Okamoto N, Era T, Sugiyama H, Wada T, Fukunaga K. Shioda N, et al. Among authors: yamaguchi k. Nat Med. 2018 Jun;24(6):802-813. doi: 10.1038/s41591-018-0018-6. Epub 2018 May 21. Nat Med. 2018. PMID: 29785027
Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons.
Shioda N, Imai Y, Yabuki Y, Sugimoto W, Yamaguchi K, Wang Y, Hikida T, Sasaoka T, Mieda M, Fukunaga K. Shioda N, et al. Among authors: yamaguchi k. J Neurosci. 2019 Sep 18;39(38):7551-7563. doi: 10.1523/JNEUROSCI.0079-19.2019. Epub 2019 Aug 1. J Neurosci. 2019. PMID: 31371425 Free PMC article.
SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome.
Yamaguchi K, Shioda N, Yabuki Y, Zhang C, Han F, Fukunaga K. Yamaguchi K, et al. Int J Mol Sci. 2018 Sep 18;19(9):2811. doi: 10.3390/ijms19092811. Int J Mol Sci. 2018. PMID: 30231518 Free PMC article.
Feedback